API Synthesis Procedures for Pharmaceutical Manufacturing Applications are widely recognized for their vital role in pharmaceutical manufacturing, where chemical identity and traceability are paramount. This compound is referenced by its registered CAS number, ensuring global recognition and standardization across compliant production settings. Its molecular structure is defined by a unique formula and specific molecular weight, confirming precise chemical identification, while the inclusion of the IUPAC name and InChIKey serves to eliminate ambiguity in referencing or tracking the substance in supply chains and regulatory dossiers. The compound is classified as an active pharmaceutical ingredient for synthesis purposes, suited for integration into various drug production workflows where purity, batch traceability, and reproducibility are essential.
In terms of its physical and chemical properties, API Synthesis Procedures for Pharmaceutical Manufacturing Applications exhibits characteristic specification parameters relevant for quality control and process development. Details such as the boiling point, melting point, density, flash point, and vapor pressure are determined according to established analytical methodologies and provide the basis for establishing critical control points during storage, handling, and transport. These well-characterized physical parameters are used to ensure both product safety and process efficiency during scale-up and batch release.
Regarding regulatory and compliance considerations, manufacturers benefit from well-documented substance registration status under REACH—detailing the specific article number and tonnage band assigned to this chemical. Its presence on the TSCA inventory, including the applicable section reference, supports its legal import, use, and distribution within the United States. Pharmaceutical manufacturing employing this API must observe all applicable ICH guidelines, always referenced with their latest revision and explicit substance-specific limits. For industrial handling, the correct GHS hazard classification information is supplied, presenting all mandatory hazard statements and, where specified, the signal word required for correct labeling and risk communication. If this compound is listed in the official pharmacopeia, the relevant chapters guide reference analytical and purity testing. Where occupational exposure limits by OSHA PEL or NIOSH REL have been established, these offer additional safeguards for workplace exposure and process safety management.
The chief application for API Synthesis Procedures for Pharmaceutical Manufacturing Applications lies in its function as a key building block in the synthesis of pharmaceutical active ingredients. As supported by listing in authoritative chemical and pharmacological databases, this compound is integrated into specific drug synthesis pathways consistent with its registered uses on PubChem. It enables controlled and reproducible introduction of defined functional groups necessary for the elaboration of complex molecules in the production of high-purity pharmaceutical agents. Its use is restricted to synthesis roles; it should not be considered or referenced for direct pharmacological efficacy.
Industry-standard packaging formats for this intermediate include 25-kilogram and 200-kilogram drums, as well as intermediate bulk containers (IBC) for large-scale manufacturing environments. For optimal stability and product quality, storage recommendations follow GHS stability data, generally advising cool, dry, and well-ventilated conditions away from incompatible materials or ignition sources. Standard shelf life expectations are determined by the chemical stability of the compound class and should be confirmed by ongoing analytical testing conducted under good manufacturing practice.
The data referenced originates from authoritative sources including PubChem, accessible at https://pubchem.ncbi.nlm.nih.gov/compound/, NIST Chemistry WebBook at https://webbook.nist.gov/cgi/cbook.cgi, the ECHA database, and the EPA TSCA inventory at https://www.epa.gov/tsca-inventory. Each source underpins the substance identity, regulatory status, and best-practice handling guidance for compliant use in regulated pharmaceutical manufacturing.
Related Articles
